id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-N-0060-0003,FDA,FDA-2002-N-0060,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval;
Prescription Drug Marketing Act of 1987; Administrative Procedures, Policies, and Requirements",Notice,Notice of Approval,2003-09-15T04:00:00Z,2003,9,2003-09-16T04:00:00Z,,2025-05-13T10:10:01Z,03-23560,0,0,090000648048c02c
FDA-2002-N-0060-0002,FDA,FDA-2002-N-0060,"Agency Information Collection Activities; Submission for OMB Review; Comment Request; Prescription Drug Marketing Act of 1987; Administrative Procedures, Policies, and Requirements",Notice,General Notice,2003-05-20T04:00:00Z,2003,5,2003-05-14T04:00:00Z,,2025-05-13T10:08:30Z,03-11925,0,0,090000648048c02a
FDA-2002-N-0060-0001,FDA,FDA-2002-N-0060,"Agency Information Collection Activities; Proposed Collection; Comment Request; Prescription Drug
Marketing Act of 1987",Notice,General Notice,2002-12-03T05:00:00Z,2002,12,2002-12-02T05:00:00Z,2003-02-01T04:59:59Z,2025-05-13T10:06:39Z,02-30404,0,0,090000648048bfc7